Who owns the KENNABAMINE trademark?

The KENNABAMINE trademark is owned by Progressive Therapeutics, Inc..

What class is the KENNABAMINE trademark registered in?

The KENNABAMINE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for KENNABAMINE?

The USPTO serial number for KENNABAMINE is 98025453.

What is the registration number for KENNABAMINE?

KENNABAMINE is registered under USPTO registration number 0.

Sealvo

Home Search: KENNABAMINEKENNABAMINE #98025453

Back

Updated Sep 28, 2026·24 searches this week

View on USPTO TSDR Find similar marks

KEN

USPTO Trademark Record

PENDING

KENNABAMINE

SN 98025453·Reg 0·Filed Jun 02, 2023

Owner Progressive Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

KENNABAMINE (Serial No. 98025453), Registration No. 0, is a pending US trademark filed on Jun 02, 2023 by Progressive Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for KENNABAMINE (SN 98025453) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

KENNABAMINE (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 02, 2023

SERIAL

98025453

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateJun 02, 2023

Serial Number98025453

Registration No.0

Registration DateDec 31, 1969

Status DateFeb 26, 2026

Published for OppositionJul 01, 2025

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1767937

480Nov 21, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 27, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 26, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 26, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 26, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 26, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 01, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 01, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 25, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 02, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

May 30, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 30, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 30, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 30, 2025

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 22, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 22, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 22, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Feb 26, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Feb 26, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 26, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 26, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 07, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 06, 2023

NEW APPLICATION ENTERED

Other Marks by Progressive Therapeutics, Inc.

Additional USPTO filings from the same owner.

PRO

PROGRESSIVE

73629883

PROGRESSIVE THERAPEUTICS, INC.

ABANDONED

Other Marks by Jeffrey J. Ellison

Additional USPTO filings handled by the same attorney of record.

COR

CORBUS PHARMACEUTICALS

86722578

REGISTERED

LOG

LogoMark

86722494

REGISTERED

INS

INSPIRNA

90706226

REGISTERED

AND

ANDALA

90763983

REGISTERED

KENNABAMINE

Run a conflict check

Other Marks by Progressive Therapeutics, Inc.

Other Marks by Jeffrey J. Ellison

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company